Created Immediately Artificial Pancreas

 Artificial pancreas will be created by the scientists of diabetes with insulin pump manufacturer, Animas.
The Juvenile Diabetes Research Foundation (JDRF) on Wednesday (13 / 1) suggests local time, they choose the unit from Johnson & Johnson is to develop and try new technologies, namely the pump and control system for type-1 diabetes.

"This will be a research and development of the first stage towards the creation of artificial pancreas," he said. Henry Anhalt, director of medical affairs of Animas, as quoted by Maggie Fox of Reuters.

Animas will work with the foundation that creates a combination of recording devices of glucose, insulin pumps, and some software to wireless technology. The new system will facilitate the people with diabetes to check blood and inject insulin.

The goal is a tool that can check the blood at any time and inject insulin as needed, without the help of others. This means that this technology into the future to just one package, either insulin pump or glucose entry system only.

"Herein lies the magical power, when the tool is able to communicate with each other. Now the tool is already available but still separate, "said Alan Lewis, chief executive officer and president of the JDRF.

The trust has spent years working with centers of knowledge to build a perfect system and could be marketed.

"Animas is a body that provides the equipment. JDRF will be a partner that uses our knowledge and expertise, "said Lewis again.

Foundation was poured eight million dollars for the next three years for the project. The goal is to have the first generation technology of these sophisticated devices that can be evaluated during the next four years.

Type-1 diabetes is a disease "autoimune", ie actually the body's immune system destroying the pancreas cells that produce insulin. Body no longer able to dissolve and use the sugar. If not treated, it will damage the blood vessels and nerves, organs, and eventually died.

In fact, if untreated, the blood vessels and damaged organs remain, blindness, kidney failure, and even loss of limbs. In the United States (U.S.) estimated three million people, average children and adolescents, diabetes type-1.

"This could be a first aid for not only improve glucose control but also lift the entire burden," said Aaron Kowalsky from JDRF.

Is rudimentary software that regulates insulin pumps and blood sugar that is not too high or low. Animas and JDRF will work together to find the best formula for it and try it.

"No single algorithm was consistent with the symptoms of the patient," said Anhallt, a specialist child pancreas organs.

According to Lewis, DexCom Inc.. which creates glucose control equipment that will provide their products become part of the package.

"We believe that Animas is a field leader that will allow us to market a product," said Lewis. The target is to create technology that is trusted by physicians, patients, and parents.

"All parents who have to wake up every night to check her blood sugar levels will be more relieved that their children are no longer going up because his blood sugar levels are very low," review Kowalski, who also suffered from type-1 diabetes.

He added, "Here the quality of life are not exaggerated." (AntaraNews)